Searched for
DIABETOLOGY
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Want to reverse prediabetes? Exercise 150 minutes a week and add these superfoods to control blood sugarReversing prediabetes involves a combination of regular exercise and a balanced diet. Experts recommend at least 150 minutes of moderate ph...
- Biocon Biologics mulls raising up to Rs 4,500 crore in bondsThe company is in discussions with banks for the issuance, the people said, asking not to be named because the details are private. Funds f...
- Celebrating unsung heroes at The Economic Times - Doctors Day Conclave
- Biocon to expand generic drugs business with DKSHAs a part of the pact, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various ther...
- Diabetics at higher risk of dying from Covid-19, experts recommend regular monitoring of blood glucoseAt present, more than 77 million people in India are living with diabetes.
- Torrent Pharma completes acquisition of Unichem Laboratories Ltdhe acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like ...
- Lupin launches generic drug to treat depression in USLupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations,...
- KIMS hospitals invests Rs 40 crore in 100-bed hospital in IT corridor of HyderabadIn addition to the existing facilities in the two states, KIMS is also spreading its footprint across country by establishing hospitals in ...
- Torrent Pharma board approves Zyg Pharma's amalgamationTorrent Pharmaceuticals today said its board has given nod to the scheme of amalgamation of its subsidiary Zyg Pharma with the company.
- Lupin launches generic version of Celebrex in US marketLupin had earlier signed a licensing agreement with Pfizer Inc for Celebrex, which has an annual sales of $ 2.54 billion in US market, it a...
- Unichem Lab Q2 net profit up 3% at Rs 36.2 croreUnichem Laboratories on Saturday reported a 3.22 per cent increase in net profit to Rs 36.2 crore for the quarter ended September 30 as sal...
- Unichem Q2 net up 83.22 pc at Rs 35.07 crorerug firm Unichem Laboratories today said its net profit rose by 83.22 crore cent to Rs 35.07 crore for the quarter ended September 30, 2012...
- Biocon to enter hospital infections treatment segmentThe company will introduce five new products in the initial phase of launch for the treatment of critical illnesses like septicemia and oth...
- Lupin enters gynaecology segmentDrug major Lupin on Wednesday said its domestic business will continue to focus on lifestyle segment and it has entered the gynaecology seg...
- Dr Reddy's commences operations in PhilippinesIndia's drug maker Dr Reddy's Laboratories Ltd today said it has opened a new office in Manila, Philippines in partnership with Britton Mar...
- Elder Pharma, Enzymotec ink in-licensig dealElder enters into the agreement for launching a cholesterol reducing dietary supplement in India.
Load More
